MetaADEDB 2.0 @ LMMD
Valturna
(AYFQOWOITXDUOI-MTFPVJPISA-N)
Structure
SMILES
CCCCC(=O)N([C@H](C(=O)O)C(C)C)Cc1ccc(cc1)c1ccccc1c1n[nH]nn1.COCCCOc1cc(ccc1OC)C[C@H](C(C)C)C[C@@H]([C@H](C[C@@H](C(=O)NCC(C(=O)N)(C)C)C(C)C)O)N
Molecular Formula:
C54H82N8O9
Molecular Weight:
987.277
Log P:
9.2467
Hydrogen Bond Acceptor:
16
Hydrogen Bond Donor:
6
TPSA:
258.2
CAS Number(s):
N/A
Synonym(s)
1.
Valturna
External Link(s)
PubChem Compound23231644
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Cerebrovascular accidentFAERS: 16US FAERS
2Diabetes MellitusFAERS: 12US FAERS
3HypotensionFAERS: 9US FAERS
4AngioedemaFAERS: 8US FAERS
5Blood potassium increasedFAERS: 7US FAERS
6DizzinessFAERS: 7US FAERS
7AnhedoniaFAERS: 5US FAERS
8Blood creatinine increasedFAERS: 5US FAERS
9MalaiseFAERS: 5US FAERS
10PainFAERS: 5US FAERS
11Drug ineffectiveFAERS: 4US FAERS
12Wrong technique in drug usage processFAERS: 4US FAERS
13Abdominal discomfortFAERS: 3US FAERS
14AnxietyFAERS: 3US FAERS
15Blood pressure inadequately controlledFAERS: 3US FAERS
16Chest PainFAERS: 3US FAERS
17Drug dose omissionFAERS: 3US FAERS
18DysarthriaFAERS: 3US FAERS
19Feeling abnormalFAERS: 3US FAERS
20HeadacheFAERS: 3US FAERS
21AlopeciaFAERS: 2US FAERS
22AstheniaFAERS: 2US FAERS
23Blood urea increasedFAERS: 2US FAERS
24ConstipationFAERS: 2US FAERS
25DeafnessFAERS: 2US FAERS
26Erectile dysfunctionFAERS: 2US FAERS
27HypersensitivityFAERS: 2US FAERS
28InfectionFAERS: 2US FAERS
29Lip swellingFAERS: 2US FAERS
30MicroalbuminuriaFAERS: 2US FAERS
31Nerve injuryFAERS: 2US FAERS
32ProteinuriaFAERS: 2US FAERS
33Skin UlcerFAERS: 2US FAERS
34SyncopeFAERS: 2US FAERS
35AneurysmFAERS: 1US FAERS
36AphasiaFAERS: 1US FAERS
37AtelectasisFAERS: 1US FAERS
38BlindnessFAERS: 1US FAERS
39Blood sodium decreasedFAERS: 1US FAERS
40CataractFAERS: 1US FAERS
41CellulitisFAERS: 1US FAERS
42Cerebral InfarctionFAERS: 1US FAERS
43Chest discomfortFAERS: 1US FAERS
44CholelithiasisFAERS: 1US FAERS
45Coronary Artery DiseaseFAERS: 1US FAERS
46Diabetes mellitus inadequate controlFAERS: 1US FAERS
47DiverticulitisFAERS: 1US FAERS
48GlaucomaFAERS: 1US FAERS
49GlomerulonephritisFAERS: 1US FAERS
50HemiparesisFAERS: 1US FAERS
51Hepatitis CFAERS: 1US FAERS
52Hypertensive crisisFAERS: 1US FAERS
53HypoxiaFAERS: 1US FAERS
54Left Ventricular HypertrophyFAERS: 1US FAERS
55Metastatic NeoplasmFAERS: 1US FAERS
56Muscle SpasticityFAERS: 1US FAERS
57MyalgiaFAERS: 1US FAERS
58Myocardial InfarctionFAERS: 1US FAERS
59ObesityFAERS: 1US FAERS
60PresyncopeFAERS: 1US FAERS
61ProstatectomyFAERS: 1US FAERS
62PruritusFAERS: 1US FAERS
63Respiratory FailureFAERS: 1US FAERS
64ScreamingFAERS: 1US FAERS
65SluggishnessFAERS: 1US FAERS
66Supraventricular tachycardiaFAERS: 1US FAERS
67SwellingFAERS: 1US FAERS
68ThrombocytopeniaFAERS: 1US FAERS
69VIIth nerve paralysisFAERS: 1US FAERS
70Visual ImpairmentFAERS: 1US FAERS
71Vitreous DetachmentFAERS: 1US FAERS
72Walking aid userFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.